Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer

Cancer Letters(2023)10.1016/j.canlet.2023.216437Source: DataRank Database

Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.20)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sugantha Priya Elayapillai ORCID,Dongfeng Qu ORCID,Kamille Pitts ORCID,Alexander Filatenkov ORCID,Courtney W. Houchen ORCID

Live enrichment

PubMed:37838282 PMC:PMC10872611 OpenAlex:https://openalex.org/W4387579955

NIGMS NIH HHS

Grant: P20 GM103639

NCI NIH HHS

Grant: P30 CA225520

NCI NIH HHS

Grant: R44 CA224472

FWCI

2.20

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10872611/pdf/nihms-1943651.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0304383523003889?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383523003889?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10872611

Fields of Study

Hippo pathway signaling and YAP/TAZCaveolin-1 and cellular processesCancer Cells and MetastasisMedicineHumansFemaleDoublecortin-Like KinasesCisplatinDrug Resistance, NeoplasmIntracellular Signaling Peptides and ProteinsCell Line, TumorNeoplasm Recurrence, LocalProtein Serine-Threonine KinasesOvarian Neoplasms

MeSH Terms

Doublecortin-Like KinasesCisplatinFemaleHumansNeoplasm Recurrence, LocalOvarian NeoplasmsProtein Serine-Threonine KinasesDrug Resistance, NeoplasmCell Line, TumorIntracellular Signaling Peptides and Proteins

Keywords

CisplatinCancer researchOvarian cancerMetastasisCancerBiologyKinaseMedicineChemotherapyInternal medicineCell biologyCombination therapyChemoresistanceSpheroidsDclk1

Sustainable Development Goals

SDG 0: No povertySDG 0: Good health and well-being